Join to View Full Profile
593 Eddy StProvidence, RI 02903
Dr. Ollila is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Thomas Ollila, MD is an Oncologist specializing in Hematologic Oncology based in Providence, RI. He completed his medical education at Drexel University College of Medicine in 2012 and had his residency in Internal Medicine at Brown University the same year. He has numerous publications in reputable journals such as Blood Advances, British Journal of Haematology, and Frontiers in Oncology. His research topics have covered areas such as CAR-T therapy, follicular lymphoma, and primary central nervous system lymphoma.
Education & Training
Rhode Island Hospital/Brown University HealthResidency, Internal Medicine, 2012
Drexel University College of MedicineClass of 2012
Certifications & Licensure
RI State Medical License 2012 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Quality-of-life endpoints collection, reporting, and framing in randomised trials of indolent lymphomas: a systematic review.Charles J Milrod, Lila Rubin, Boris Martinez, Thomas A Ollila, Adam J Olszewski
The Lancet. Haematology. 2025-04-01 - Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy.Reem Karmali, Geoffrey Shouse, Pallawi Torka, Tamara K Moyo, Jason Romancik
Blood Cancer Journal. 2025-03-26 - 3 citationsProgression-free survival is a weakly predictive surrogate end-point for overall survival in follicular lymphoma: A systematic review and meta-analysis.Charles J Milrod, Kang Woo Kim, Christina Raker, Thomas A Ollila, Adam J Olszewski
British Journal of Haematology. 2024-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
